The Association of Hypertension with Increased Mortality Rate During the COVID-19 Pandemic: An Update with

Ahmad R Al-Qudimat1,2, Ayisha Ameen3, Doaa M Sabir3

  • 1Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar. aalqudimat@hamad.qa.

Insights

Hypertension is linked to increased COVID-19 mortality, but other factors like comorbidities and age also significantly raise death risks. This review highlights the complex interplay of risk factors in COVID-19 outcomes.

Area of Science:

  • Public Health
  • Epidemiology
  • Internal Medicine

Background:

  • The COVID-19 pandemic has seen numerous studies on risk factors for mortality.
  • Hypertension (HTN) is a common comorbidity, and its association with COVID-19 mortality requires comprehensive updates.

Approach:

  • A systematic review and meta-analysis were conducted following PRISMA guidelines.
  • Searches were performed on PubMed, Scopus, and Cochrane databases for studies published between December 2019 and August 2022.
  • 23 observational studies with over 611,000 patients were included.

Key Points:

  • The overall mortality prevalence in the included studies was 0.5% (3119 deaths out of 611,522 patients).
  • Pooled mortality rates varied significantly across studies.
  • Subgroup analyses indicated that male patients with hypertension had a slightly lower mortality risk compared to female patients, particularly when men constituted over 50% of the cohort.

Conclusions:

  • Hypertension is a significant risk factor for COVID-19 mortality.
  • However, it is not the sole determinant; other comorbidities and advanced age substantially increase mortality risk.
  • Further research into the multifactorial nature of COVID-19 mortality is warranted.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
22
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
33
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
25
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
19
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
13